Article
Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
Cancer - 15 Feb 2008
van der Knaap Ronald, Siemes Claire, Coebergh Jan-Willem W, van Duijn Cornelia M, Hofman Albert, Stricker Bruno H Ch
Abstract excerpt
BACKGROUND: Angiotensin I-converting enzyme (ACE) inhibitors, angiotensin II antagonists, and the ACE insertion/deletion (I/D) gene polymorphism all influence serum angiotensin II action. Because angiotensin II levels have been associated with cancer, the objective of the current epidemiologic study was to investigate whether renin-angiotensin system inhibitors and/or ACE genotypes were associated with an altered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
